Noninvasive Tests Cost-Effectively Identify Patients at Risk for Liver Disease
March 23, 2021
Primary care physicians and specialists face the challenges of addressing the epidemic of liver disease, including nonalcoholic fatty liver disease (NAFLD)–a silent and potentially reversible condition—and its subtype nonalcoholic steatohepatitis (NASH),
